STOCK TITAN

The Indian Ocean Region Countries Rapid Diagnostic Kits Industry is Expected to Reach $1.75 Billion by 2029: Growing Prevalence of Infectious Diseases Drives the Market

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

DUBLIN, Feb. 1, 2023 /PRNewswire/ -- The "Rapid Diagnostic Kits Market for Indian Ocean Region Countries by Product, Platform, Application, End User - Forecast to 2029" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo


The rapid diagnostics kits market for Indian Ocean region countries is expected to grow at a CAGR of 1.6% from 2022 to 2029 to reach $1.75 billion by 2029.

Following thorough secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities.

The growing demand for PoC diagnostics, the high prevalence of chronic diseases coupled with the increasing geriatric population, the growing prevalence of infectious diseases, the increasing need for rapid decision-making, and the outbreak of the COVID-19 pandemic are the key factors driving growth in the market.

However, variance in test results is a restraining factor for the growth of this market. Additionally, the reluctance to change the existing diagnostic practices is a major challenge for market growth.

Market Dynamics

Drivers

  • Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
  • Growing Prevalence of Infectious Diseases
  • Increasing Need for Rapid Decision-making & Growing Demand for Point-of-Care (POC) Diagnostics
  • The Outbreak of the COVID-19 Pandemic

Restraints

  • Variance in Test Results

Opportunities

  • Untapped Potential in Emerging Economies of the Countries in the Indian Ocean Region

Challenges

  • Reluctance toward Changing Existing Diagnostic Practices

Companies Mentioned

  • Abbott Laboratories (U.S.)
  • Becton
  • Dickinson and Company (U.S.)
  • Bio-Rad Laboratories Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • ACON Laboratories Inc. (U.S.)
  • Danaher Corporation (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • bioMerieux S.A. (France)
  • Alfa Scientific Designs Inc. (U.S.)
  • BTNX Inc. (Canada)
  • Meridian Bioscience Inc. (U.S.)
  • Trinity Biotech plc (Ireland)

Scope of the Report

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Product

  • Professional Kits
  • OTC Kits

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Platform

  • Immunoassays
  • Molecular Detection
  • Other Rapid Diagnostic Platforms

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Application

  • Infectious Diseases Testing
  • Pregnancy And Fertility Testing
  • Cardiac Metabolism Testing
  • Cholesterol Testing
  • Tumor/Cancer Markers Testing
  • Blood Glucose Testing
  • Urinalysis
  • Hematology Testing
  • Other Tests

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care/Self-testing
  • Other End Users

Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Geography

  • France
  • India
  • Australia
  • Indonesia
  • Singapore
  • Sri Lanka
  • Madagascar
  • Mauritius
  • Reunion
  • Mayotte
  • Seychelles
  • Comoros

For more information about this report visit https://www.researchandmarkets.com/r/l7uurz-diagnostic?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/the-indian-ocean-region-countries-rapid-diagnostic-kits-industry-is-expected-to-reach-1-75-billion-by-2029-growing-prevalence-of-infectious-diseases-drives-the-market-301736293.html

SOURCE Research and Markets

Trinity Biotech plc

NASDAQ:TRIB

TRIB Rankings

TRIB Latest News

TRIB Stock Data

16.38M
69.32M
29.31%
39.27%
0.02%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Bray

About TRIB

since its formation in 1992, trinity biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products. the test kits manufactured by trinity biotech are used in the clinical laboratory and point-of-care segments of the diagnostic market to detect infectious diseases, sexually transmitted diseases, autoimmune and haemoglobin disorders, and detect, monitor and control diabetes. the company is also a significant provider of raw materials to the life sciences industry. trinity biotech, which has its headquarters in ireland, employs in excess of 350 people and markets its portfolio of over 400 products to customers in 80 countries around the world. it reaches this worldwide market by combining the